Buerger 病

Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg. 1991;5:570-572.

• 摘要

Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn. 1989;39:153-158.

• 摘要

Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990;82(5 suppl)IV3-IV8.

• 摘要

Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci. 1908;136:567-580.

Shionoya S. Pathology. In: Shionoya S, ed. Buerger's disease. Nagoya: University of Nagoya Press; 1990:57-79.

Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg. 1996;11:335-339.

• 摘要

Ohta T, Ishioashi H, Hosaka M, et al. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39:176-180.

• 摘要

Cacione DG, Macedo CR, Baptista-Silva JC. Pharmacological treatment for Buerger's disease. Cochrane Database Syst Rev. 2016;(3):CD011033.

• 摘要

1.  Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg. 1991;5:570-572.

• 摘要

2.  Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn. 1989;39:153-158.

• 摘要

3.  Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990;82(5 suppl)IV3-IV8.

• 摘要

4.  Yorukoglu Y, Ilgit E, Zengin M, et al. Thromboangiitis obliterans (Buerger's disease) in women (a reevaluation). Angiology. 1993;44:527-532.

• 摘要

5.  Arkkila PET. Thromboangiitis obliterans (Buerger's disease) Orphanet J Rare Dis. 2006; 1: 14.

• 全文

6.  Buerger L. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci. 1908;136:567-580.

7.  Rahman M, Chowdhury AS, Fukui T, et al. Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: a case-control study. Int J Epidemiol. 2000:29:266-270.

• 全文
• 摘要

8.  Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited - ten new case reports. Angiology. 2001;52:1-5.

• 摘要

9.  Allen EV, Brown GE. Thrombo-angiitis obliterans: a clinical study of 200 cases: I. etiology, pathology, symptoms, diagnosis. Ann Intern Med. 1928;1:535-549.

10.  Iwai T, Inoue Y, Umeda M, et al. Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg. 2005;42:107-115.

• 摘要

11.  Iwai T. Periodontal bacteremia and various vascular diseases. J Periodontal Res. 2009;44:689-694.

• 摘要

12.  Kjeldsen K, Mozes M. Buerger's disease in Israel. Investigations on carboxyhemoglobin and serum cholesterol levels after smoking. Acta Chir Scand. 1969;135:495-498.

• 摘要

13.  Chen Z, Nakajima T, Inoue Y, et al. A single nucleotide polymorphism in the 3'-untranslated region of MyD88 gene is associated with Buerger disease but not with Takayasu arteritis in Japanese. J Hum Genet. 2011;56:545-547.

• 摘要

14.  Makita S, Nakamura M, Murakami H, et al. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation. 1996;94(9 suppl):II211-II215.

• 摘要

15.  Papa M, Bass A, Adar R, et al. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex. Surgery. 1992;111:527-531.

• 摘要

16.  Dellalibera-Joviliano R, Joviliano EE, Evora PR. Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans. Scand J Immunol. 2010;72:128-133.

• 摘要

17.  Lie JT. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum. 1988;31:812-813.

• 摘要

18.  Joyce JW. Buerger's disease (thromboangiitis obliterans). Rheum Dis Clin North Am. 1990;16:463-470.

• 摘要

19.  Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med. 2002;7:259-264.

• 摘要

20.  Chen YW, Nagasawa T, Wara-Aswapati N, et al. Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J Clin Periodontol. 2009;36:830-835.

• 摘要

21.  Chen Z, Takahashi M, Naruse T, et al. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum Genet. 2007;122:367-372.

• 摘要

22.  Sasaki S, Sakuma M, Kunihara T, et al. Distribution of arterial involvement in thromboangiitis obliterans (Buerger's disease): results of a study conducted by the Intractable Vasculitis Syndromes Research Group in Japan. Surg Today. 2000;30:600-605.

• 摘要

23.  Puechal X, Fiessinger JN, Kahan A, et al. Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease). J Rheumatol. 1999;26:1764-1768.

• 摘要

24.  Juergens JL. Thromboangiitis obliterans (Buerger's disease, TAO). In: Juergens JL, Spittel JA, Fairbairn JF, eds. Peripheral vascular disease. Philadelphia, PA: WB Saunders; 1980:469-491.

25.  Hill GL. A rational basis for management of patients with Buerger syndrome. Br J Surg. 1974;61:476-481.

• 摘要

26.  Shionoya S. Pathology. In: Shionoya S, ed. Buerger's disease. Nagoya: University of Nagoya Press; 1990:57-79.

27.  Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg. 1996;11:335-339.

• 摘要

28.  Sasajima T, Kubo Y, Inaba M, et al. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience. Eur J Vasc Endovasc Surg. 1997;13:186-192.

• 摘要

29.  Ohta T, Ishioashi H, Hosaka M, et al. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39:176-180.

• 摘要

30.  O'Dell JR, Linder J, Markin RS, et al. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum. 1987;30:1054-1056.

• 摘要

31.  Palomo Arellano A, Gomez Tello V, Parilla Herranz P, et al. Buerger's disease starting in the upper extremity: a favorable response to nifedipine treatment combined with stopping tobacco use. An Med Interna. 1990;7:307-308.

• 摘要

32.  Agarwal P, Agrawal PK, Sharma D, et al. Intravenous infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers. J Eur Acad Dermatol Venereol. 2005;19:158-162.

• 摘要

33.  Ohashi S, Iwatani M, Hyakuna Y, et al. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. Arzneimittelforschung. 1985;35:1203-1208.

• 摘要

34.  Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO study. Lancet. 1990;335:555-557.

• 摘要

35.  Bozkurt AK, Koksal C, Demirbas MY, et al. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease. Int Angiol. 2006;25:162-168.

• 摘要

36.  Cacione DG, Macedo CR, Baptista-Silva JC. Pharmacological treatment for Buerger's disease. Cochrane Database Syst Rev. 2016;(3):CD011033.

• 摘要

37.  The European TAO Study Group. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. Eur J Vasc Endovasc Surg. 1998;15:300-307.

• 全文
• 摘要

38.  Donas KP, Schulte S, Ktenidis K, et al. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg. 2005;41:830-836.

• 摘要

39.  Manfredini R, Boari B, Gallerani M, et al. Thromboangiitis obliterans (Buerger disease) in a female mild smoker treated with spinal cord stimulation. Am J Med Sci. 2004;327:365-368.

• 摘要

40.  Broseta J, Barbera J, de Vera JA, et al. Spinal cord stimulation in peripheral arterial disease: a cooperative study. J Neurosurg. 1986;64:71-80.

• 摘要

41.  Stümpflen A, Ahmadi A, Attender M, et al. Effects of transvenous regional guanethidine block in the treatment of critical finger ischemia. Angiology. 2000;51:115-122.

• 摘要

42.  Paraskevas KI, Trigka AA, Samara M. Successful intravenous regional sympathetic blockade (Bier's Block) with guanethidine and lidocaine in a patient with advanced Buerger's Disease (thromboangiitis obliterans) - a case report. Angiology. 2005;56:493-496.

• 摘要

43.  Chander J, Singh L, Lal P, et al. Retroperitoneoscopic lumbar sympathectomy for Buerger's disease: a novel technique. JSLS. 2004;8:291-296.

• 摘要

44.  Lau H, Cheng SW. Buerger's disease in Hong Kong: a review of 89 cases. Aust NZ J Surg. 1997;67:264-269.

• 摘要

45.  Kothari R, Sharma D, Thakur DS, et al. Thoracoscopic dorsal sympathectomy for upper limb Buerger's disease. JSLS. 2014;18:273-276.

• 全文
• 摘要

46.  Segers B, Himpens J, Barroy JP. Retroperitoneal laparoscopic bilateral lumbar sympathectomy. Acta Chir Belg. 2007;107:341-342.

• 摘要

47.  Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209:10-17.

• 摘要

48.  Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med. 2000;343:864-869.

• 摘要

49.  Sasaki S, Sakuma M, Yasuda K. Current status of thromboangiitis obliterans (Buerger's disease) in Japan. Int J Cardiol. 2000;75(suppl 1):S175-S181.

• 摘要

50.  Talwar S, Jain S, Porwal R, et al. Free versus pedicled omental grafts for limb salvage in Buerger's disease. Aust NZ J Surg. 1998;68:38-40.

• 摘要

51.  Isner JM, Baumgartner I, Rauh G, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg. 1998;28:964-973.

• 摘要

52.  Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet. 2002;360:427-435.

• 摘要

53.  Idei N, Soga J, Hata T, et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv. 2011;4:15-25.

• 全文
• 摘要

54.  Todoli Parra JA, Hernández MM, Arrébola López MA. Efficacy of bosentan in digital ischemic ulcers. Ann Vasc Surg. 2010;24:690.e1-e4.

• 摘要

55.  Szuba A, Cooke JP. Thromboangiitis obliterans: an update on Buerger's disease. West J Med. 1998;168:255-260.

• 全文
• 摘要

56.  Cooper LT, Tse TS, Mikhail MA, et al. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol. 2004;44:2410-2411.

• 摘要

57.  Ates A, Yekeler I, Ceviz M, et al. One of the most frequent vascular diseases in northeastern of Turkey: thromboangiitis obliterans or Buerger's disease (experience with 344 cases). Int J Cardiol. 2006;111:147-153.

• 摘要

58.  Szuba A, Wysokinski W, Czarnacki M, et al. Coexistence of Buerger's disease with atherosclerosis obliterans. In: 9th International symposium on atherosclerosis. 1991; abstract 178.